YI - Utang jangka dawa perusahaan 111, Inc.

The daily price chart for 111, Inc. (YI) reflects the performance of a company developing China's largest digital hub for pharmaceutical sales, leveraging government support and the online trend. The business is pursuing self-sufficiency through direct B2B transactions with factories while avoiding mergers, and the metric stands at 0.00. The marketplace's cloud IT infrastructure enables rapid turnover growth without incurring personnel or warehousing costs.

The specifics of 111, Inc. (YI) digital pharmacy operations amid PRC regulatory pressure and delisting risks necessitate strict capital control. By analyzing the corporation's long-term loans and borrowings, an investor assesses the total liabilities with a maturity of over one year, which allows for the determination of the liability structure's stability and the risk of credit default, characterizing the securities as an instrument with a moderate risk profile.